加州大学论坛 UCBBS.org

 找回密码
 注册Register(需身份验证,用Paylal或支付宝获取邀请码或向会员索取)

QQ登录

只需一步,快速开始

扫一扫,访问微社区

查看: 2860|回复: 0
打印 上一主题 下一主题

PRESENTATION: Pharmaceutical R&D innovation and collaboration

[复制链接]
跳转到指定楼层
楼主
发表于 2014-1-8 23:17:37 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
From: Des Jarlais, Christine
Sent: Tuesday, January 07, 2014 4:21 PM
To: Postdoc Listserv
Cc: Lindstaedt, Bill; Katsuura, Rachel (Bunkers-Harmes); Kaufteil, Andrew; Groves, Brian; Nigorizawa, Holly; Winkler, Wendy; Kreitzer, Faith; Augustyn, Kari; Sam Castañeda; Cuevas, Jeannine
Subject: PRESENTATION: Pharmaceutical R&D innovation and collaboration in China, Asia and Emerging Markets


Dear Postdocs,


You are invited to attend this presentation.


Title: Pharmaceutical R&D innovation and collaboration in China, Asia and Emerging Markets

Date: Tuesday, January 14

Time: 12:00 – 1:00

Place: Genentech Hall, Room N114, Mission Bay


Presenter:

Steve Yang, PhD (UCSF Alum)

VP, Head of Asia and Emerging Markets iMed

AstraZeneca - Innovative Medicines & Early Development



Light refreshments provided. No registration required.


Steve Yang
Vice President, Head of Asia and Emerging Markets iMed
AstraZeneca
Dr. Steve Yang is Vice President, and Head of Asia and Emerging Markets iMed at AstraZeneca. He is based in Shanghai, China and is responsible for developing, implementing and aligning the company’s R&D strategy for Asia and Emerging Markets.  His main responsibilities include managing AstraZeneca’s research, early development and translational science efforts in China, ensuring the successful implementation of the company’s R&D strategy for Asia, and developing and executing the R&D strategy for Emerging Market countries outside Asia.
Prior to joining AstraZeneca, Dr. Yang was Vice President, Head of Asia R&D at Pfizer, where he was charged with establishing and expanding thecompany’s research partnership network with academic institutions, biotechnology firms and Contract Research Organizations across Asia Pacific. He was also responsible for delivering a portfolio of preclinical and clinicalstage projects targeting unmet medical needs of emerging markets.  Prior to his leadership position in Asia, Dr. Yang was Executive Director and head of the company’s global R&D strategic management group.
Before joining Pfizer, Dr. Yang held a number of positions at IntraBiotics Pharmaceuticals, a US-based biotech company and also worked for Strategic Decisions Group (SDG), a management consulting firm for Fortune 100 companies.
Dr Yang is the co-founder of the BayHelix Group, a non-profit professional organization of Chinese life science business leaders.
Dr. Yang received his PhD in Pharmaceutical Chemistry from the University of California, San Francisco, USA. He started his undergraduate study in Fudan University, China and completed his BS Summa Cum Laude in Biology from Michigan Technological University, USA.




___________



Christine D. Des Jarlais, EdD

Assistant Dean for Postdocs & Career Development

Graduate Division

University of California, San Francisco


1675 Owens Street, Suite 310

San Francisco, CA 94143-0523



分享到:  QQ好友和群QQ好友和群 QQ空间QQ空间 腾讯微博腾讯微博 腾讯朋友腾讯朋友 微信微信
收藏收藏
加州大学论坛',www.ucbbs.org,欢迎您! 服务于美国西海岸加州地区著名大学,为海外和内地中国留学生,博士后,学者及社区华人提供房屋出租、租房等生活信息和沟通交流的平台.
回复

使用道具 举报

本版积分规则

赞助捐赠、广告合作请联系我们 support@ucbbs.org  , 谢谢您的支持!

Contact us 联系我们|Darkroom|手机版|Archiver|加州大学论坛 UCBBS.ORG (Universities in California Bulletin Board System)

GMT-8, 2024-10-31 16:12 , Processed in 0.056938 second(s), 31 queries .

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表